跳至主要内容
临床试验/NCT00930501
NCT00930501Unknown不适用

Phase 1 Prospective Study of Markers of Ovarian Reserve in Young Female Cancer Patients

Hadassah Medical Organization1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
1
主要终点
Anti mullerian hormone

研究概览

简要总结

young female cancer patients have improving chances of survival. the main risk is a chronic damage to their ovarian reserve. This may lead to future infertility.

详细描述

our objective is to prospectively follow patients before and after their cancer treatment. this should help us learn of the gonadotoxicity of various treatments as well as be able to better consult these and future patients of the need of fertility preservation techniques.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
5 Years 至 45 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • all females prior and after chemotherapy

排除标准

  • do not consent

结局指标

主要结局

Anti mullerian hormone

时间窗: 2 years

次要结局

  • inhibin b(2 years)
  • antral follicle count(2 years)
  • FSH(2 years)
  • E2 and prog(2 years)
  • menstrual history(2 years)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验